denotes emergency department, and IQR interquartile range. † Race was determined by the clinical team. ‡ Obesity was defined as a body-mass index (the weight in kilograms divided by the square of the height in meters) of 30 or higher.
Background: Some reports suggest that obesity could be a risk factor for complications in coronavirus disease 2019 (COVID-19) (1). Several mechanisms could explain this. First, adipocytes, which activate the inflammatory cascade, can increase risk for thromboembolism and susceptibility to the cytokine storm described in COVID-19 (2). Second, obesity negatively affects lung mechanics, which could predispose obese persons to more severe respiratory distress and failure (3). Finally, obesity can alter mitochondrial bioenergetics in lung epithelial cells and increase risk for acute lung injury (4). However, some have suggested an obesity paradox in some critical illnesses, including acute respiratory distress syndrome, where patients with obesity may have improved outcomes; whether this phenomenon occurs in patients with COVID-19 is unclear (5). Objective: To study the association between obesity and outcomes among a diverse cohort of 1687 persons hospitalized with confirmed COVID-19 at 2 New York City hospitals. Methods and Findings: This retrospective observational cohort study included consecutive adults with confirmed COVID-19 who were hospitalized between 3 March and 15 May 2020 at an 862-bed quaternary referral center or a 180bed community hospital in New York City. We excluded 46 patients who did not have height or weight data available to calculate body mass index (BMI). Patient data were manually abstracted (1) from the electronic health record through 6 June 2020. We determined BMI on the basis of the most recent height and weight listed in the electronic health record. Height and weight were collected during hospitalization for 95.5% of the cohort; the remaining BMIs were collected during ambulatory encounters within 3 months of hospitalization. We defined BMI categories as underweight (<18.5 kg/m 2), normal (18.5 to 24.9 kg/m 2), overweight (25.0 to 29.9 kg/m 2), mild to moderate obesity (30.0 to 39.9 kg/m 2), and morbid obesity (≥40.0 kg/m 2). To examine the association between BMI and in-hospital mortality, we used a Cox proportional hazards model adjusted for age, sex, race, smoking, diabetes, hypertension, chronic obstructive pulmonary disease, asthma, end-stage renal disease, coronary artery disease, heart failure, and cancer. These characteristics were chosen on the basis of risk factors for severe COVID-19 identified by the Centers for Disease Control and Prevention. We also examined for effect modification by age, sex, and race. To examine the association between BMI and respiratory failure, defined as a need for invasive mechanical ventilation, we used a Fine and Gray model to account for the competing risk for death and adjusted for the same 12 variables used in the model for mortality. We excluded the underweight group from this analysis because of low numbers. Finally, we repeated the adjusted Cox proportional hazards model analysis for mortality among persons with respiratory failure, again excluding the underweight group. To account for missing data (12% for race), we did multiple imputation.
BackgroundSuccessfully transitioning patients from hospital to home is a complex, often uncertain task. Despite significant efforts to improve the effectiveness of care transitions, they remain a challenge across health care systems. The lens of complex adaptive systems (CAS) provides a theoretical approach for studying care transition interventions, with potential implications for intervention effectiveness. The aim of this study is to examine whether care transition interventions that are congruent with the complexity of the processes and conditions they are trying to improve will have better outcomes.MethodsWe identified a convenience sample of high-quality care transition intervention studies included in a care transition synthesis report by Kansagara and colleagues. After excluding studies that did not meet our criteria, we scored each study based on (1) the presence or absence of 5 CAS characteristics (learning, interconnections, self-organization, co-evolution, and emergence), as well as system-level interdependencies (resources and processes) in the intervention design, and (2) scored study readmission-related outcomes for effectiveness.ResultsForty-four of the 154 reviewed articles met our inclusion criteria; these studies reported on 46 interventions. Nearly all the interventions involved a change in interconnections between people compared with care as usual (96% of interventions), and added resources (98%) and processes (98%). Most contained elements impacting learning (67%) and self-organization (69%). No intervention reflected either co-evolution or emergence. Almost 40% of interventions were rated as effective in terms of impact on hospital readmissions. Chi square testing for an association between outcomes and CAS characteristics was not significant for learning or self-organization, however interventions rated as effective were significantly more likely to have both of these characteristics (78%) than interventions rated as having no effect (32%, p = 0.005).ConclusionsInterventions with components that influenced learning and self-organization were associated with a significant improvement in hospital readmissions-related outcomes. Learning alone might be necessary but not be sufficient for improving transitions. However, building self-organization into the intervention might help people effectively respond to problems and adapt in uncertain situations to reduce the likelihood of readmission.Electronic supplementary materialThe online version of this article (10.1186/s12913-018-3712-7) contains supplementary material, which is available to authorized users.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.